相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epigenetics as a mediator of plasticity in cancer
Andrew P. Feinberg et al.
SCIENCE (2023)
Osimertinib-tolerant lung cancer cells are susceptible to ferroptosis
Hiroto Konishi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2023)
Cancer statistics, 2023
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2023)
Cell-Intrinsic Mechanisms of Drug Tolerance to Systemic Therapies in Cancer
Camille Leonce et al.
MOLECULAR CANCER RESEARCH (2022)
Sublethal cytochrome c release generates drug-tolerant persister cells
Halime Kalkavan et al.
CELL (2022)
Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy
Sumaiyah K. Rehman et al.
CELL (2021)
Assessing eukaryotic initiation factor 4F subunit essentiality by CRISPR-induced gene ablation in the mouse
Patrick Senechal et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells
Clement Larrue et al.
NATURE COMMUNICATIONS (2021)
Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence
Cihangir Duy et al.
CANCER DISCOVERY (2021)
Fighting Drug Resistance through the Targeting of Drug-Tolerant Persister Cells
Giulia De Conti et al.
CANCERS (2021)
Evolution of delayed resistance to immunotherapy in a melanoma responder
David Liu et al.
NATURE MEDICINE (2021)
Emerging Insights into Targeted Therapy-Tolerant Persister Cells in Cancer
Heidie Frisco Cabanos et al.
CANCERS (2021)
The great escape: tumour cell plasticity in resistance to targeted therapy
Soufiane Boumahdi et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway
Kari J. Kurppa et al.
CANCER CELL (2020)
ALDH1A3-mTOR axis as a therapeutic target for anticancer drug-tolerant persister cells in gastric cancer
Ryuhei Kawakami et al.
CANCER SCIENCE (2020)
YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation
Takahiro Tsuji et al.
NATURE COMMUNICATIONS (2020)
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer
Marcus Ruscetti et al.
CELL (2020)
Translational efficiency across healthy and tumor tissues is proliferation-related
Xavier Hernandez-Alias et al.
MOLECULAR SYSTEMS BIOLOGY (2020)
Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours
Joao M. Fernandes Neto et al.
NATURE COMMUNICATIONS (2020)
Tolerant/Persister Cancer Cells and the Path to Resistance to Targeted Therapy
Mirna Swayden et al.
CELLS (2020)
EGFR inhibition triggers an adaptive response by co-opting antiviral signaling pathways in lung cancer
Ke Gong et al.
NATURE CANCER (2020)
NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism
Douglas B. Fox et al.
NATURE METABOLISM (2020)
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC
Silvia La Monica et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
Gloria V. Echeverria et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance
Shun Li et al.
NATURE COMMUNICATIONS (2019)
Identification of ryuvidine as a KDM5A inhibitor
Eishin Mitsui et al.
SCIENTIFIC REPORTS (2019)
Transcriptomic analysis associated with reversal of cisplatin sensitivity in drug resistant osteosarcoma cells after a drug holiday
Divya Niveditha et al.
BMC CANCER (2019)
Adaptive mutability of colorectal cancers in response to targeted therapies
Mariangela Russo et al.
SCIENCE (2019)
A global transcriptomic pipeline decoding core network of genes involved in stages leading to acquisition of drug-resistance to cisplatin in osteosarcoma cells
Divya Niveditha et al.
BIOINFORMATICS (2019)
KDM5B Promotes Drug Resistance by Regulating Melanoma-Propagating Cell Subpopulations
Xiaoni Liu et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Targeting Cancer Cell Dormancy
Ariadna Recasens et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
Hirokazu Taniguchi et al.
NATURE COMMUNICATIONS (2019)
An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells
Shensi Shen et al.
NATURE COMMUNICATIONS (2019)
Senescence-associated reprogramming promotes cancer stemness
Maja Milanovic et al.
NATURE (2018)
Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression
Maria Rusan et al.
CANCER DISCOVERY (2018)
Tumor cell-intrinsic phenotypic plasticity facilitates adaptive cellular reprogramming driving acquired drug resistance
Heinz Hammerlindl et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress
Jennifer Tsoi et al.
CANCER CELL (2018)
Toward Minimal Residual Disease-Directed Therapy in Melanoma
Florian Rambow et al.
CELL (2018)
Glutathione metabolism in cancer progression and treatment resistance
Ankita Bansal et al.
JOURNAL OF CELL BIOLOGY (2018)
TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer
Ke Gong et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Targeting glioma stem-like cell survival and chemoresistance through inhibition of lysine-specific histone demethylase KDM2B
Mikkel Staberg et al.
MOLECULAR ONCOLOGY (2018)
Harnessing Tumor Evolution to Circumvent Resistance
Katherine L. Pogrebniak et al.
TRENDS IN GENETICS (2018)
NF-κB activation is an early event of changes in gene regulation for acquiring drug resistance in human adenocarcinoma PC-9 cells
Masashi Fukuoka et al.
PLOS ONE (2018)
A dynamic N-6-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors
Fei Yan et al.
CELL RESEARCH (2018)
NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination
Marcus Ruscetti et al.
SCIENCE (2018)
Microenvironment-Induced Non-sporadic Expression of the AXL and cKIT Receptors Are Related to Epithelial Plasticity and Drug Resistance
Tina A. Jokela et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
Increased Synthesis of MCL-1 Protein Underlies Initial Survival of EGFR-Mutant Lung Cancer to EGFR Inhibitors and Provides a Novel Drug Target
Kyung-A Song et al.
CLINICAL CANCER RESEARCH (2018)
Rare cell variability and drug- induced reprogramming as a mode of cancer drug resistance
Sydney M. Shaffer et al.
NATURE (2017)
Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
Matthew J. Hangauer et al.
NATURE (2017)
Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells
Elodie M. Kuntz et al.
NATURE MEDICINE (2017)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Persistent bacterial infections and persister cells
Robert A. Fisher et al.
NATURE REVIEWS MICROBIOLOGY (2017)
Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance
Yapeng Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Antibiotic tolerance facilitates the evolution of resistance
Irit Levin-Reisman et al.
SCIENCE (2017)
Recurrent Tumor Cell-Intrinsic and -Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early Adaptation
Chunying Song et al.
CANCER DISCOVERY (2017)
Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
Thomas Farge et al.
CANCER DISCOVERY (2017)
Distinct histone modifications denote early stress-induced drug tolerance in cancer
Abdullah Al Emran et al.
Oncotarget (2017)
High-Throughput Functional Genetic and Compound Screens Identify Targets for Senescence Induction in Cancer
Liqin Wang et al.
CELL REPORTS (2017)
Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors
Maithili P. Dalvi et al.
CELL REPORTS (2017)
Genome Regulation by Polycomb and Trithorax: 70 Years and Counting
Bernd Schuettengruber et al.
CELL (2017)
Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure
Gulfem Dilek Guler et al.
CANCER CELL (2017)
Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance
Brian B. Liau et al.
CELL STEM CELL (2017)
Early dissemination seeds metastasis in breast cancer
Hedayatollah Hosseini et al.
NATURE (2016)
An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells
Maia Vinogradova et al.
NATURE CHEMICAL BIOLOGY (2016)
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
Aaron N. Hata et al.
NATURE MEDICINE (2016)
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh et al.
SCIENCE (2016)
Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells
Michael Ramirez et al.
NATURE COMMUNICATIONS (2016)
Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling
Eishu Hirata et al.
CANCER CELL (2015)
Molecular Changes Associated with Acquired Resistance to Crizotinib in ROS1-Rearranged Non-Small Cell Lung Cancer
Ahnah Song et al.
CLINICAL CANCER RESEARCH (2015)
The epigenetic/noncoding origin of tumor dormancy
Francesco Crea et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition
Aaron Goldman et al.
NATURE COMMUNICATIONS (2015)
NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer
Collin M. Blakely et al.
CELL REPORTS (2015)
A stress-induced early innate response causes multidrug tolerance in melanoma
D. Ravindran Menon et al.
ONCOGENE (2015)
The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation
Debasish Raha et al.
CANCER RESEARCH (2014)
An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia
Birgit Knoechel et al.
NATURE GENETICS (2014)
Single-cell analyses of transcriptional heterogeneity during drug tolerance transition in cancer cells by RNA sequencing
Mei-Chong Wendy Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Timing and heterogeneity of mutations associated with drug resistance in metastatic cancers
Ivana Bozic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
mTOR Inhibition Specifically Sensitizes Colorectal Cancers with KRAS or BRAF Mutations to BCL-2/BCL-XL Inhibition by Suppressing MCL-1
Anthony C. Faber et al.
CANCER DISCOVERY (2014)
Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells
Alexander Roesch et al.
CANCER CELL (2013)
Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models
Ryan B. Corcoran et al.
CANCER CELL (2013)
Drug rechallenge and treatment beyond progression-implications for drug resistance
Elizabeth A. Kuczynski et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
M. Angela Nieto
SCIENCE (2013)
Histone H3 lysine 4 methyltransferases and demethylases in self-renewal and differentiation of stem cells
Bingnan Gu et al.
CELL AND BIOSCIENCE (2013)
Identification of cancer stem cells in vincristine preconditioned SGC7901 gastric cancer cell line
Zengfu Xue et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhenfeng Zhang et al.
NATURE GENETICS (2012)
The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway
Wanjin Hong et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
MET-Independent Lung Cancer Cells Evading EGFR Kinase Inhibitors Are Therapeutically Susceptible to BH3 Mimetic Agents
Weiwen Fan et al.
CANCER RESEARCH (2011)
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
Piyush B. Gupta et al.
CELL (2011)
Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma
Jonathan H. Schatz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Persisters: Survival at the Cellular Level
Clinton C. Dawson et al.
PLOS PATHOGENS (2011)
Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4E
Andrew C. Hsieh et al.
CANCER CELL (2010)
4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors
Qing-Bai She et al.
CANCER CELL (2010)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
Identification of Therapeutic Targets for Quiescent, Chemotherapy-Resistant Human Leukemia Stem Cells
Yoriko Saito et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
GAS6/AXL Axis Regulates Prostate Cancer Invasion, Proliferation, and Survival in the Bone Marrow Niche
Yusuke Shiozawa et al.
NEOPLASIA (2010)
Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition
Nikolaos A. Dallas et al.
CANCER RESEARCH (2009)
Stability of Eukaryotic Translation Initiation Factor 4E mRNA Is Regulated by HuR, and This Activity Is Dysregulated in Cancer
Ivan Topisirovic et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Shared principles in NF-κB signaling
Matthew S. Hayden et al.
CELL (2008)
Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic
Mark S. Cragg et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
mTORC1 promotes survival through translational control of Mcl-1
John R. Mills et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cap-dependent eukaryotic initiation factor-mRNA interactions probed by cross-linking
Lisa Lindqvist et al.
RNA (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
Mutation as a stress response and the regulation of evolvability
Rodrigo S. Galhardo et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
M Narita et al.
CELL (2003)
A novel protein, RTN-xS, interacts with both Bcl-xL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity
S Tagami et al.
ONCOGENE (2000)
分享论文
